Inventor · disambiguated record
Peter Brent Sampson
Also filed as: SAMPSON PETER · SAMPSON PETER B · SAMPSON PETER BRENT
33 granted patents·3 pending applications·232 citations·filing 2003–2021
97Inventor score
Top patents by PatentIndex Score
36 records- 0195US8263596B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2011·Granted Sep 11, 2012·26 cites·10 claims
- 0294US9139563B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2013·Granted Sep 22, 2015·14 cites·9 claims
- 0394US8481533B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2012·Granted Jul 9, 2013·24 cites·20 claims
- 0492US9907800B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2015·Granted Mar 6, 2018·7 cites·6 claims
- 0592US9573954B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2013·Granted Feb 21, 2017·13 cites·22 claims
- 0691US8481525B2Kinase inhibitors and method of treating cancer with sameSAMPSON PETER BRENT·Filed 2010·Granted Jul 9, 2013·27 cites·33 claims
- 0790US10358436B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2018·Granted Jul 23, 2019·4 cites·6 claims
- 0890US9884855B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2014·Granted Feb 6, 2018·8 cites·20 claims
- 0990US8999968B2Kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2013·Granted Apr 7, 2015·13 cites·13 claims
- 1089US10919886B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2019·Granted Feb 16, 2021·2 cites·22 claims
- 1189US8921545B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesCUMMING GRAHAM·Filed 2011·Granted Dec 30, 2014·15 cites·14 claims
- 1289US8765748B2Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancerPAULS HEINZ W·Filed 2008·Granted Jul 1, 2014·16 cites·17 claims
- 1388US10501474B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2016·Granted Dec 10, 2019·3 cites·2 claims
- 1487US10472353B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2019·Granted Nov 12, 2019·3 cites·20 claims
- 1587US10106545B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Oct 23, 2018·4 cites·21 claims
- 1687US9796703B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Oct 24, 2017·4 cites·9 claims
- 1786US10584130B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 1886USRE47731EKinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2018·Granted Nov 19, 2019·4 cites·13 claims
- 1986US10392374B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2018·Granted Aug 27, 2019·3 cites·17 claims
- 2086US9579327B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2014·Granted Feb 28, 2017·5 cites·16 claims
- 2184US11104681B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2020·Granted Aug 31, 2021·1 cites·19 claims
- 2284US10570143B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Granted Feb 25, 2020·2 cites·21 claims
- 2384US8318720B2Acrylamide derivatives as Fab I inhibitorsPAULS HEINZ W·Filed 2007·Granted Nov 27, 2012·7 cites·34 claims
- 2483US10077255B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Sep 18, 2018·2 cites·25 claims
- 2582US7790709B2Heterocyclic compounds, methods of making them and their use in therapyAFFINIUM PHARM INC·Filed 2003·Granted Sep 7, 2010·12 cites·14 claims
- 2680US8450307B2Therapeutic agents, and methods of making and using the sameSARGENT BRUCE J·Filed 2005·Granted May 28, 2013·9 cites·22 claims
- 2779US11878980B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2021·Granted Jan 23, 2024·0 cites·8 claims
- 2879US8895545B2Acrylamide derivatives as Fab I inhibitorsAFFINIUM PHARM INC·Filed 2012·Granted Nov 25, 2014·2 cites·20 claims
- 2977US11667627B2Salt and crystal forms of PLK-4 inhibitorUNIV HEALTH NETWORK·Filed 2021·Granted Jun 6, 2023·0 cites·11 claims
- 3069US11059832B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2019·Granted Jul 13, 2021·0 cites·10 claims
- 3169US2022002313A1Hpk1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 3254US8410150B2Inhibitors of carnitine palmitoyltransferase and treating cancerPAULS HEINZ W·Filed 2008·Granted Apr 2, 2013·0 cites·20 claims
- 3349US8680282B2Cyclic inhibitors of carnitine palmitoyltransferase and treating cancerPAULS HEINZ W·Filed 2008·Granted Mar 25, 2014·0 cites·11 claims
- 3449US2011124633A1Heterocyclic Compounds, Methods of Making Them and Their Use in TherapyBERMAN JUDD·Filed 2010·Application pending·0 cites
- 3548US2014107106A1Therapeutic agents, and methods of making and using the sameAFFINIUM PHARM INC·Filed 2013·Application pending·0 cites
- 3643US9580390B2Indazole compounds as kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2012·Granted Feb 28, 2017·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Peter Brent Sampson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →